Article Information
History
- January 8, 2022.
Article Versions
- Version 1 (January 4, 2022 - 09:06).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Mario A. Peña-Hernández1,2,*,
- Jon Klein1,3,*,
- Amyn A. Malik4,5,*,
- Andreas Coppi4,6,*,
- Chaney Kalinich7,*,
- Chantal B. F. Vogels7,
- Julio Silva1,3,
- Yale SARS-CoV-2 Genomic Surveillance Initiative7,
- David R. Peaper8,
- Marie-Louise Landry8,9,10,
- Craig Wilen1,8,
- Nathan D. Grubaugh7,
- Wade Schulz6,8,
- Saad B. Omer5,7,9,11 and
- Akiko Iwasaki1,7,12,13,‡
- 1Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA
- 2Department of Microbial Pathogenesis, Yale School of Medicine, New Haven, CT, USA
- 3MD/PhD Program, Yale School of Medicine, New Haven, CT, USA
- 4Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA
- 5Yale Institute for Global Health, Yale School of Public Health, New Haven, CT, USA
- 6Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT, USA
- 7Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
- 8Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA
- 9Section of Infectious Diseases, Department of Medicine, Yale School of Medicine, New Haven, CT, USA
- 10Clinical Virology Laboratory, Yale New Haven Health, New Haven, CT, USA
- 11Yale School of Nursing, Yale University, New Haven, CT, USA
- 12Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, US
- 13Howard Hughes Medical Institute, Chevy Chase, MD, USA
- ↵‡Corresponding Author email: akiko.iwasaki{at}yale.edu
↵* Indicates equal contributions